Project Grant K01CA301031
Award Date 8/13/26
Completion Date 7/31/31
Dollars Obligated $303K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07107, USA
Similar Awards
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $599,978 under the Cancer Cause and Prevention Research program (CFDA 93.393) on July 1, 2026. The award funds a five-year prospective cohort study examining the relationship between perceived social obligations and clinical and patient-reported outcomes in 315 patients with advanced, poor-prognosis cancer. The research tests the hypothesis that higher patient-reported...
- The National Cancer Institute awarded a cooperative agreement to Rutgers The State University of New Jersey for $975,000 on March 21, 2026, under the Cancer Treatment Research program (CFDA 93.395). The award funds clinical trial support infrastructure and operations for the Rutgers Cancer Institute and RWJBarnabas Health System across multiple hospital sites within the health system. The award supports a centralized research administration model through the Office of Human Research Services,...
- The National Cancer Institute awarded Rutgers, The State University of New Jersey, School of Nursing $239,352 on August 11, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop a sequencing-free PCR-based method for deep T-cell receptor profiling using sloppy molecular beacons in single-cell droplet digital PCR. The recipient will deliver a diagnostic technique that identifies T-cell receptor variable gene segment usage while preserving alpha-beta chain...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $516,808 under the Cancer Treatment Research program (CFDA 93.395) on June 1, 2026, to elucidate the mechanism of targeting methionine synthase (MTR) to enhance anti-tumor immunity in KRAS-driven lung cancer. The recipient will conduct research to understand how MTR targeting enhances immune responses in KRAS-driven non-small cell lung cancer (NSCLC), which exhibits...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, School of Nursing, $723,569 under the Cancer Cause and Prevention Research program (CFDA 93.393) on September 1, 2026, to conduct a prospective epidemiologic study examining associations between the human gut microbiome and postmenopausal breast cancer risk. The research leverages the Nurses' Health Study II cohort, which includes over 18,000 women with pre-diagnostic stool samples and repeated assessments of...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $170,930 under Project Grant R03CA308463 on April 1, 2026, to support research into the longitudinal dynamics of blood microbiome and circulating tumor cells in metastatic breast cancer. The research applies a novel reduced metagenomic sequencing technique to analyze longitudinal plasma samples from women with metastatic triple-negative breast cancer (MTNBC), using liquid...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $651,545 on September 1, 2026, under the Cancer Treatment Research program (CFDA 93.395) to investigate the meningeal lymphatic system as a pathogenic driver of chemotherapy-induced cognitive impairment in cancer survivors. The research targets chemobrain, a persistent cognitive dysfunction affecting pediatric and adult cancer survivors whose underlying mechanisms remain...
- The National Cancer Institute, a division of the Department of Health and Human Services, awarded $641,071 to Rutgers The State University of New Jersey (School of Nursing) on September 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct epidemiological research characterizing the role of air pollution in breast cancer prognosis and survivorship among Black women. The research leverages the Women's Circle of Health Follow-Up Study, a population-based cohort...
- The National Cancer Institute awarded Sloan-Kettering Institute for Cancer Research $294,080 on September 3, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop peripartum breast MRI (PPMRI), a non-contrast MRI technique for detecting breast cancer in pregnant and postpartum women. The award funds development of specialized MRI acquisition methods and biophysical modeling to exploit endogenous contrast mechanisms created by physiological changes during pregnancy and...
- The National Cancer Institute awarded Rutgers The State University of New Jersey $542,316 on May 7, 2026, under the Cancer Treatment Research program (CFDA 93.395) to investigate the mechanism and therapeutic potential of parkin in colorectal cancer. The funded research examines how the E3 ubiquitin ligase parkin suppresses colorectal cancer and how parkin deficiency drives metabolic reprogramming to promote disease progression. The project employs unbiased screening approaches including...